Cargando…
126 A CTS team approach to reliable delivery of aerosols to lung cells at the air-liquid interface (ALI), through Dosimetric Aerosol in Vitro Inhalation Device (DAVID)
OBJECTIVES/GOALS: In vitro models that mimic the human respiratory system are needed to assess the toxicity of inhaled contaminants. Therefore, our goal is to establish a Dosimetric Aerosol in-Vitro Inhalation Device (DAVID) that delivers aerosols in different patterns to human lung cells cultured a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129792/ http://dx.doi.org/10.1017/cts.2023.208 |
_version_ | 1785030831581954048 |
---|---|
author | Shankar, Sripriya Nannu O’Connor, Amber Le, Eric Theodore, Alex Sabo-Attwood, Tara Lewis, Gregory S. Fernandez, Arantzazu-Eiguren Wu, Chang-Yu |
author_facet | Shankar, Sripriya Nannu O’Connor, Amber Le, Eric Theodore, Alex Sabo-Attwood, Tara Lewis, Gregory S. Fernandez, Arantzazu-Eiguren Wu, Chang-Yu |
author_sort | Shankar, Sripriya Nannu |
collection | PubMed |
description | OBJECTIVES/GOALS: In vitro models that mimic the human respiratory system are needed to assess the toxicity of inhaled contaminants. Therefore, our goal is to establish a Dosimetric Aerosol in-Vitro Inhalation Device (DAVID) that delivers aerosols in different patterns to human lung cells cultured at an air-liquid interface (ALI). METHODS/STUDY POPULATION: The collection unit of DAVID was modified in this study to accommodate different deposition patterns (spots, annular ring, rectangle & circle). CuO aerosols of varying concentrations were generated using a 6-jet Collison nebulizer for varying time periods to achieve different doses. To quantify the doses that were delivered to cells, the samples were digested with nitric acid & analyzed by Inductively Coupled Plasma-Optical Emission Spectrometry. Following the exposure of A549 cells to CuO aerosols, cytotoxicity and mRNA expression (i.e., HMOX1 & IL-8) will be assessed via LDH and RT-qPCR to determine the effect of regional (mass deposited/area of the pattern) and global (mass deposited/area of the cell culture insert) doses in cells. RESULTS/ANTICIPATED RESULTS: The deposition areas covered by rectangular, spot, annular ring, and circular patterns are estimated to be 6, 17, 27 and 85% of the insert’s surface area, onto which cells are cultured. Results for the patterns tested (spots and annular ring) show that both the regional and global doses were greater for spots than annular ring. Also, the regional doses were higher than global doses. Irrespective of the patterns, the global doses were the same for nebulizer suspensions of 0.1-1 mg/mL. Statistical analysis by ANOVA revealed there was no significant difference in doses between replicate inserts used in the same trial. We anticipate that regional doses with aerosol deposition to a larger surface area of the cell culture insert will correspond with higher cytotoxicity and mRNA expression of HMOX1 and IL-8 in cells. DISCUSSION/SIGNIFICANCE: There are limited in vitro exposure systems that can efficiently deliver aerosols to lung cells, while also mimicking inhalation by humans. In addition to addressing this knowledge gap, we will show the role of regional & global doses in studying cellular response & the ability of DAVID to deliver aerosols in different deposition patterns. |
format | Online Article Text |
id | pubmed-10129792 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101297922023-04-26 126 A CTS team approach to reliable delivery of aerosols to lung cells at the air-liquid interface (ALI), through Dosimetric Aerosol in Vitro Inhalation Device (DAVID) Shankar, Sripriya Nannu O’Connor, Amber Le, Eric Theodore, Alex Sabo-Attwood, Tara Lewis, Gregory S. Fernandez, Arantzazu-Eiguren Wu, Chang-Yu J Clin Transl Sci Evaluation OBJECTIVES/GOALS: In vitro models that mimic the human respiratory system are needed to assess the toxicity of inhaled contaminants. Therefore, our goal is to establish a Dosimetric Aerosol in-Vitro Inhalation Device (DAVID) that delivers aerosols in different patterns to human lung cells cultured at an air-liquid interface (ALI). METHODS/STUDY POPULATION: The collection unit of DAVID was modified in this study to accommodate different deposition patterns (spots, annular ring, rectangle & circle). CuO aerosols of varying concentrations were generated using a 6-jet Collison nebulizer for varying time periods to achieve different doses. To quantify the doses that were delivered to cells, the samples were digested with nitric acid & analyzed by Inductively Coupled Plasma-Optical Emission Spectrometry. Following the exposure of A549 cells to CuO aerosols, cytotoxicity and mRNA expression (i.e., HMOX1 & IL-8) will be assessed via LDH and RT-qPCR to determine the effect of regional (mass deposited/area of the pattern) and global (mass deposited/area of the cell culture insert) doses in cells. RESULTS/ANTICIPATED RESULTS: The deposition areas covered by rectangular, spot, annular ring, and circular patterns are estimated to be 6, 17, 27 and 85% of the insert’s surface area, onto which cells are cultured. Results for the patterns tested (spots and annular ring) show that both the regional and global doses were greater for spots than annular ring. Also, the regional doses were higher than global doses. Irrespective of the patterns, the global doses were the same for nebulizer suspensions of 0.1-1 mg/mL. Statistical analysis by ANOVA revealed there was no significant difference in doses between replicate inserts used in the same trial. We anticipate that regional doses with aerosol deposition to a larger surface area of the cell culture insert will correspond with higher cytotoxicity and mRNA expression of HMOX1 and IL-8 in cells. DISCUSSION/SIGNIFICANCE: There are limited in vitro exposure systems that can efficiently deliver aerosols to lung cells, while also mimicking inhalation by humans. In addition to addressing this knowledge gap, we will show the role of regional & global doses in studying cellular response & the ability of DAVID to deliver aerosols in different deposition patterns. Cambridge University Press 2023-04-24 /pmc/articles/PMC10129792/ http://dx.doi.org/10.1017/cts.2023.208 Text en © The Association for Clinical and Translational Science 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work. |
spellingShingle | Evaluation Shankar, Sripriya Nannu O’Connor, Amber Le, Eric Theodore, Alex Sabo-Attwood, Tara Lewis, Gregory S. Fernandez, Arantzazu-Eiguren Wu, Chang-Yu 126 A CTS team approach to reliable delivery of aerosols to lung cells at the air-liquid interface (ALI), through Dosimetric Aerosol in Vitro Inhalation Device (DAVID) |
title | 126 A CTS team approach to reliable delivery of aerosols to lung cells at the air-liquid interface (ALI), through Dosimetric Aerosol in Vitro Inhalation Device (DAVID) |
title_full | 126 A CTS team approach to reliable delivery of aerosols to lung cells at the air-liquid interface (ALI), through Dosimetric Aerosol in Vitro Inhalation Device (DAVID) |
title_fullStr | 126 A CTS team approach to reliable delivery of aerosols to lung cells at the air-liquid interface (ALI), through Dosimetric Aerosol in Vitro Inhalation Device (DAVID) |
title_full_unstemmed | 126 A CTS team approach to reliable delivery of aerosols to lung cells at the air-liquid interface (ALI), through Dosimetric Aerosol in Vitro Inhalation Device (DAVID) |
title_short | 126 A CTS team approach to reliable delivery of aerosols to lung cells at the air-liquid interface (ALI), through Dosimetric Aerosol in Vitro Inhalation Device (DAVID) |
title_sort | 126 a cts team approach to reliable delivery of aerosols to lung cells at the air-liquid interface (ali), through dosimetric aerosol in vitro inhalation device (david) |
topic | Evaluation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129792/ http://dx.doi.org/10.1017/cts.2023.208 |
work_keys_str_mv | AT shankarsripriyanannu 126actsteamapproachtoreliabledeliveryofaerosolstolungcellsattheairliquidinterfacealithroughdosimetricaerosolinvitroinhalationdevicedavid AT oconnoramber 126actsteamapproachtoreliabledeliveryofaerosolstolungcellsattheairliquidinterfacealithroughdosimetricaerosolinvitroinhalationdevicedavid AT leeric 126actsteamapproachtoreliabledeliveryofaerosolstolungcellsattheairliquidinterfacealithroughdosimetricaerosolinvitroinhalationdevicedavid AT theodorealex 126actsteamapproachtoreliabledeliveryofaerosolstolungcellsattheairliquidinterfacealithroughdosimetricaerosolinvitroinhalationdevicedavid AT saboattwoodtara 126actsteamapproachtoreliabledeliveryofaerosolstolungcellsattheairliquidinterfacealithroughdosimetricaerosolinvitroinhalationdevicedavid AT lewisgregorys 126actsteamapproachtoreliabledeliveryofaerosolstolungcellsattheairliquidinterfacealithroughdosimetricaerosolinvitroinhalationdevicedavid AT fernandezarantzazueiguren 126actsteamapproachtoreliabledeliveryofaerosolstolungcellsattheairliquidinterfacealithroughdosimetricaerosolinvitroinhalationdevicedavid AT wuchangyu 126actsteamapproachtoreliabledeliveryofaerosolstolungcellsattheairliquidinterfacealithroughdosimetricaerosolinvitroinhalationdevicedavid |